Research and Development

Showing 15 posts of 9615 posts found.

genmab

FDA approves ‘first of its kind’ blood cancer drug

November 17, 2015 Manufacturing and Production, Research and Development

The FDA has approved Genmab’s drug Darzalex for patients with multiple myeloma. Darzalex (daratumumab) is the first human CD38 monoclonal antibody …
Diabetes treatments

Featured Market Report: Type 2 Diabetes – Epidemiology Forecast to 2024

November 16, 2015 Manufacturing and Production, Research and Development diabetes, market reports

Diabetes is one of the most common non-communicable diseases worldwide and is an escalating public health problem globally, with an …
baxalta_logo

FDA approves Baxalta Haemophilia A treatment

November 16, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

The US FDA has approved Baxalta’s twice-weekly therapy Adynovate for use in adults and adolescents, aged 12 years plus, with …
diabetes_insulin_syringes

Novo Nordisk invests $20m in diabetes research following study

November 16, 2015 Research and Development, Sales and Marketing

Novo Nordisk has unveiled plans to combat urban diabetes in a $20 million investment offering expert resources and research funds …
amgen_flag

Amgen’s Humira biosimilar succeeds in Phase III arthritis study

November 16, 2015 Research and Development, Sales and Marketing Amgen, Humira

Amgen says its Humira (adalimumab) biosimilar candidate ABP 501 proved its clinical equivalence to Abbvie’s blockbuster drug in a head-to-head …
mene_pangalos

New appointments for AstraZeneca’s Mene Pangalos

November 13, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Mene Pangalos, executive vice president of the IMED Biotech Unit at AstraZeneca UK, has accepted two prestigious appointments that …
google logo

Google and AHA to fund $50m cardiovascular disease project

November 13, 2015 Medical Communications, Research and Development American Heart Association, cardiovascular disease, google, heart disease

The American Heart Association and Google Life Sciences have announced a joint research collaboration to bring ‘unconventional thinking’ to the …
BI building

Boehringer cuts R&D budget to €11bn to focus on collaborations

November 13, 2015 Medical Communications, Research and Development Boehringer Ingelheim

Boehringer Ingelheim has launched its new research and development strategy, committing €11 billion to R&D over the next five years. …
Proteus Digital and Otuska's 'digital pill'

The ‘Pharmasaurus’ aims to evolve into a leader in the digital age

November 12, 2015 Medical Communications, Research and Development Bayer, Roche, digital health, pharma

Pharma’s new-found willingness to embrace all aspects of the digital age, and use it both to its advantage and that …
Benlysta

GSK ready for lupus drug push

November 12, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, GSK, Lupus, SLE, belimumab, systemic lupus erythematosus

Having presented positive late-stage results for a new formulation of its inflammatory drug Benlysta, GSK says it will file supplementary …

Astellas to acquire Ocata Therapeutics in $379m buyout

November 11, 2015 Research and Development, Sales and Marketing Astellas, Ocata, Stem cells, cell therapy, ophthalmology

Astellas Pharma has agreed to buy Ocata, a firm specialising in cloning and embryonic stem cell therapies, for $379 million. …
roche

FDA approves Roche skin cancer combination

November 11, 2015 Research and Development, Sales and Marketing Cotellic, FDA, Genentech, Roche, Zelboraf, cobimetinib, melanoma, skin cancer, vemurafenib

The FDA has approved the skin cancer drug Cotellic for certain forms of melanoma in combination with another Roche cancer …
ABPI

UK ‘lacks the skills’ for future drug development, ABPI warns

November 11, 2015 Business Services, Research and Development ABPI, Jobs, careers, recruitment, skills gap

A shortage of skilled professionals threatens to undermine research and development of new medicines in the UK and prevent growth …
Victoza

Novo Nordisk looks to HEOR data to back Victoza

November 11, 2015 Research and Development, Sales and Marketing Byetta, HEOR, Lyxumia, NHS, Novo Nordisk, Victoza, cost-effectiveness

A Novo Nordisk-sponsored study of the cost-effectiveness of three different injectable anti-diabetes drugs has found Victoza is a cheaper option …

Lilly/Incyte RA drug bests Humira in Phase III trial

November 10, 2015 Research and Development Humira, baricitinib, lilly, phase III, rheumatoid arthritis

Eli Lilly says its investigational therapy baricitinib outperformed AbbVie’s Humira after 12 weeks in a late-stage study of people with …
The Gateway to Local Adoption Series

Latest content